0000899243-22-016594.txt : 20220504
0000899243-22-016594.hdr.sgml : 20220504
20220504161216
ACCESSION NUMBER: 0000899243-22-016594
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220502
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maduck Sean
CENTRAL INDEX KEY: 0001698310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 22891628
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-02
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001698310
Maduck Sean
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
0
1
0
0
See Remarks
Stock Option (Right to Buy)
22.05
2022-05-02
4
A
0
50000
0.00
A
2032-05-01
Common Stock
50000
50000
D
Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of April 6, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on April 6, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
President, Corcept Endocrinology
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Sean Nicholas Maduck
2022-05-04